Akebia Therapeutics, Inc. (AKBA) vs EyePoint Pharmaceuticals, Inc. (EYPT)
A side-by-side comparison of Akebia Therapeutics, Inc. and EyePoint Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKBA
Akebia Therapeutics, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
EYPT
EyePoint Pharmaceuticals, Inc.
$3.18HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — AKBA vs EYPT
growth of $100 · dividends reinvested · last 10yAKBA -89.7% (-20.4%/yr)EYPT -89.5% (-20.2%/yr)EYPT compounded faster over this window
AKBA EYPT
AKBA vs EYPT: by the numbers
- •EYPT is the larger company ($267M vs $242M market cap).
- •Both run net losses; AKBA's is the smaller (-13.54% vs -10994.73% net margin).
- •Both shrank revenue over the past five years; AKBA's decline was smaller (-0.26% vs -41.05% CAGR).
Metrics side by side
Valuation
| Metric | AKBA | EYPT |
|---|---|---|
| P/S ratio | 1.10 | 95.60 |
| P/B ratio | 9.66 | 1.60 |
| FCF yield | 16.62% | N/A |
Profitability
| Metric | AKBA | EYPT |
|---|---|---|
| Gross margin | 79.48% | 93.41% |
| Operating margin | 9.95% | -775.98% |
| Net margin | -13.54% | -10994.73% |
| ROE | -118.58% | -184.27% |
| ROIC | -7.08% | -170.19% |
Growth (annualized)
| Metric | AKBA | EYPT |
|---|---|---|
| Revenue CAGR (5Y) | -0.26% | -41.05% |
| Total return CAGR (5Y) | -20.07% | -21.68% |
Frequently asked
- Which has grown faster, AKBA or EYPT?
- Neither grew: over the past five years both shrank revenue, with AKBA's decline the smaller — AKBA at a -0.26% CAGR versus EYPT at -41.05%.
- How have AKBA and EYPT total returns compared?
- Over the past 10 years, AKBA delivered -20.53% and EYPT delivered -20.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Akebia Therapeutics ROEEyePoint Pharmaceuticals ROEAkebia Therapeutics operating marginEyePoint Pharmaceuticals operating marginAkebia Therapeutics revenue growthEyePoint Pharmaceuticals revenue growthAkebia Therapeutics free cash flowEyePoint Pharmaceuticals free cash flow
Akebia Therapeutics & EyePoint Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.